AT299216B - Verfahren zur Herstellung von neuen s-Triazinen - Google Patents

Verfahren zur Herstellung von neuen s-Triazinen

Info

Publication number
AT299216B
AT299216B AT347371A AT347371A AT299216B AT 299216 B AT299216 B AT 299216B AT 347371 A AT347371 A AT 347371A AT 347371 A AT347371 A AT 347371A AT 299216 B AT299216 B AT 299216B
Authority
AT
Austria
Prior art keywords
triazines
preparation
new
Prior art date
Application number
AT347371A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AT299216B publication Critical patent/AT299216B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT347371A 1970-07-15 1970-07-31 Verfahren zur Herstellung von neuen s-Triazinen AT299216B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5524070A 1970-07-15 1970-07-15

Publications (1)

Publication Number Publication Date
AT299216B true AT299216B (de) 1972-06-12

Family

ID=21996600

Family Applications (2)

Application Number Title Priority Date Filing Date
AT347371A AT299216B (de) 1970-07-15 1970-07-31 Verfahren zur Herstellung von neuen s-Triazinen
AT697670A AT299965B (de) 1970-07-15 1970-07-31 Verfahren zur Herstellung von neuen s-Triazinen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT697670A AT299965B (de) 1970-07-15 1970-07-31 Verfahren zur Herstellung von neuen s-Triazinen

Country Status (8)

Country Link
US (1) US3755322A (de)
AT (2) AT299216B (de)
AU (1) AU1826570A (de)
BE (1) BE754242A (de)
CA (1) CA982577A (de)
FR (1) FR2099730A5 (de)
GB (1) GB1339749A (de)
NL (1) NL7011392A (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928344A (en) * 1971-12-27 1975-12-23 Degussa Phenylenediamine-s-triazines
IT1060458B (it) * 1975-12-18 1982-08-20 Chimosa Chimica Organica Spa Composti piperidil triazinici adatti per la stabilizzazione di polimeri sintetici e procedimento per la loro preparazione
DE3006803A1 (de) * 1980-02-23 1981-09-03 Bayer Ag, 5090 Leverkusen Vulkanisationsbeschleuniger auf basis von melaminderivaten, melaminderivate enthaltende kautschukmassen sowie ein verfahren zur vulkanisation von kautschuken
DE3401675A1 (de) * 1984-01-19 1985-07-25 Bayer Ag, 5090 Leverkusen Neue polyamine und ein verfahren zu ihrer herstellung
DE3438694A1 (de) * 1984-10-23 1986-04-24 Basf Ag, 6700 Ludwigshafen Neue amidoalkylmelamine und aminoalkylmelamine und verfahren zu ihrer herstellung
EP0945447A1 (de) * 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituierte 1,3,5-Triazinderivate zur Behandlung von HIV Infektionen
KR100620402B1 (ko) * 1998-11-10 2006-09-13 얀센 파마슈티카 엔.브이. 2,4-이치환된 트리아진 유도체
US6225378B1 (en) * 1999-07-01 2001-05-01 Industrial Technology Research Institute Triazine hardener and epoxy composition containing the same
EE04991B1 (et) 1999-09-24 2008-04-15 Janssen Pharmaceutica N.V. Osake, ravimvorm, nende valmistamismeetodid, osakeste kasutamine ning farmatseutiline pakend
US6660731B2 (en) * 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
WO2002022603A1 (en) 2000-09-15 2002-03-21 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
PT1345922E (pt) 2000-12-21 2006-09-29 Vertex Pharma Compostos de pirazole uteis como inibidores de proteina-quinase
CA2475633C (en) * 2002-02-06 2013-04-02 Vertex Pharmaceuticals Incorporated Heteroaryl compounds useful as inhibitors of gsk-3
EP1485380B1 (de) * 2002-03-15 2010-05-19 Vertex Pharmaceuticals Incorporated Azolylaminoazine als proteinkinasehemmer
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
CN1319968C (zh) 2002-08-02 2007-06-06 沃泰克斯药物股份有限公司 用作gsk－3的抑制剂的吡唑组合物
WO2004072029A2 (en) * 2003-02-06 2004-08-26 Vertex Pharmaceuticals Incorporated Pyrazolopyridazines useful as inhibitors of protein kinases
WO2005056547A2 (en) * 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
AU2005279615A1 (en) * 2004-09-03 2006-03-09 Prometic Biosciences Inc. 2,4,6-triamino-s-triazine-based compounds which bind to the tail (Fc) portion of immunoglobulins and their use
ITMI20050222A1 (it) * 2005-02-15 2006-08-16 Milano Politecnico Lipidi cationici per la trasfezione di acidi nucleici
AU2006279376B2 (en) * 2005-08-18 2011-04-14 Vertex Pharmaceuticals Incoporated Pyrazine kinase inhibitors
MX2008005717A (es) * 2005-11-03 2008-10-15 Vertex Pharma Aminopirimidinas utiles como inhibidores de la cinasa.
NZ576750A (en) * 2006-11-02 2012-01-12 Vertex Pharma Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
EP2099787B1 (de) * 2006-12-19 2010-07-21 Vertex Pharmaceuticals, Inc. Als inhibitoren von proteinkinasen geeignete aminopyrimidine
AU2008226461A1 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyridines useful as inhibitors of protein kinases
AU2008226466B2 (en) * 2007-03-09 2013-06-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
JP5520057B2 (ja) * 2007-03-09 2014-06-11 バーテックス ファーマシューティカルズ インコーポレイテッド 蛋白キナーゼの阻害剤として有用なアミノピリミジン
CA2683785A1 (en) 2007-04-13 2008-10-23 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
WO2008137622A2 (en) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
CA2694381A1 (en) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
NZ580884A (en) 2007-05-02 2012-02-24 Vertex Pharma Thiazoles and pyrazoles useful as kinase inhibitors
JP2010528021A (ja) * 2007-05-24 2010-08-19 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼのインヒビターとして有用なチアゾールおよびピラゾール
CN101790532B (zh) * 2007-07-31 2013-11-20 沃泰克斯药物股份有限公司 5-氟-1H-吡唑并[3，4-b]吡啶-3-胺及其衍生物的制备方法
KR20110050549A (ko) * 2008-09-03 2011-05-13 버텍스 파마슈티칼스 인코포레이티드 공-결정 및 이를 포함하는 제약 제제
ES2740424T3 (es) 2009-03-13 2020-02-05 Agios Pharmaceuticals Inc Métodos y composiciones para trastornos relacionados con la proliferación celular
AU2010266386C1 (en) 2009-06-29 2017-03-09 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
ES2594402T3 (es) 2009-10-21 2016-12-20 Agios Pharmaceuticals, Inc. Métodos y composiciones para trastornos relacionados con la proliferación celular
CA2834602C (en) 2011-05-03 2020-10-06 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use in therapy
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
WO2013018071A2 (en) * 2011-08-04 2013-02-07 Colourtex Industries Limited Fibre reactive azo reactive colorants containing two reactive groups of the vinylsulfone type, production and use thereof
US9511565B2 (en) * 2011-08-12 2016-12-06 Ube Industries, Ltd. Polyimide precursor, polyimide, polyimide film, and method for manufacturing triazine compound used for manufacturing same
EP2800743B1 (de) 2012-01-06 2018-04-04 Agios Pharmaceuticals, Inc. Therapeutische wirkstoffverbindungen und verfahren zu ihrer verwendung
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
CN104583273B (zh) * 2012-05-14 2018-01-30 国立大学法人岩手大学 聚酰亚胺前体、聚酰亚胺、聚酰亚胺膜、聚酰亚胺金属层压体及聚酰亚胺溶液
CA2888360A1 (en) 2012-10-15 2014-04-24 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
WO2015006591A1 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer
CA2917592A1 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer
US9579324B2 (en) * 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
CN105473560B (zh) * 2013-07-11 2020-01-17 安吉奥斯医药品有限公司 治疗活性化合物及其使用方法
WO2015003360A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
CN112159391A (zh) 2014-03-14 2021-01-01 阿吉奥斯制药公司 治疗活性化合物的药物组合物
SI3307271T1 (sl) 2015-06-11 2023-11-30 Agios Pharmaceuticals, Inc. Postopki za uporabo aktivatorjev piruvat kinaze
IL258684B2 (en) 2015-10-15 2023-04-01 Agios Pharmaceuticals Inc Combination therapy including an isocitrate dehydrogenase (1idh) inhibitor for use in the treatment of acute myelogenous leukemia (aml) characterized by the presence of a mutant allele of 1idh
MX2018004586A (es) 2015-10-15 2018-08-16 Agios Pharmaceuticals Inc Terapia de combinacion para tratar tumores malignos.
CN108640881A (zh) * 2018-04-26 2018-10-12 江汉大学 一种二胺单体及其合成方法
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
CN116790213B (zh) * 2023-07-04 2024-02-20 江苏特丽亮新材料科技有限公司 一种耐高温导电胶及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH441351A (de) * 1964-06-02 1967-08-15 Geigy Ag J R Verfahren zur Herstellung N2-substituierter 2,4,6-Triamino-1,3,5-triazine
DE1620178A1 (de) * 1965-12-03 1970-03-12 Ruhrchemie Ag Verfahren zur Herstellung von Aminoalkylamino-s-triazinen
US3637685A (en) * 1967-05-15 1972-01-25 Monacelli Walter J Triamino-s-triazines

Also Published As

Publication number Publication date
AT299965B (de) 1972-07-10
GB1339749A (en) 1973-12-05
BE754242A (fr) 1971-02-01
US3755322A (en) 1973-08-28
NL7011392A (de) 1972-01-18
AU1826570A (en) 1972-02-03
FR2099730A5 (de) 1972-03-17
CA982577A (en) 1976-01-27

Similar Documents

Publication Publication Date Title
AT299216B (de) Verfahren zur Herstellung von neuen s-Triazinen
AT313268B (de) Verfahren zur Herstellung von neuen 5-Aroylpyrrolderivaten
AT303040B (de) Verfahren zur Herstellung von neuen Azidophenyl-1,4-dihydroppyridinen
AT315856B (de) Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen
AT304530B (de) Verfahren zur Herstellung von neuen substituierten Phenyl-2-pyrrolidinonen
AT306238B (de) Verfahren zur Herstellung von neuen 3-Formylcephalosporinsulfoxyden
AT314729B (de) Verfahren zur Herstellung von neuen 3-Hydroxy-3-methylcephamverbindungen
AT306010B (de) Verfahren zur Herstellung von neuen Nitrofuryl-triazolo-pyrimidinen
AT306260B (de) Verfahren zur Herstellung von neuen 3-Amino-cardenoliden
AT306046B (de) Verfahren zur Herstellung von neuen semicyclischen Amidinen
ATA1046871A (de) Verfahren zur herstellung von neuen 1-aminoisochinolinen
AT312171B (de) Verfahren zur Herstellung von neuen Imidazolribosylcyclophosphaten
AT313901B (de) Verfahren zur Herstellung von neuen Tetrahydropyrimidinverbindungen
CH545305A (de) Verfahren zur Herstellung von neuen 3-Guanidinoalkylthiophenen
AT308103B (de) Verfahren zur Herstellung von neuen Tetrazol-Anthrachinonverbindungen
AT310761B (de) Verfahren zur Herstellung von neuen Triazolobenzodiazepin-5N-oxyd-Derivaten
AT299945B (de) Verfahren zur Herstellung von neuen Isoxazolyläthyl-tetrahydropyranolen
AT321271B (de) Verfahren zur Herstellung von neuen Phenylhydraziden
AT306259B (de) Verfahren zur Herstellung von neuen 3-Oxo-11β,18-epoxy-17α-R-17β-hydroxyöstra-4,9-dienen
AT305301B (de) Verfahren zur Herstellung von neuen 6-Chlorpyridaziniumverbindungen
AT305280B (de) Verfahren zur Herstellung von neuen v-Triazolen
AT315149B (de) Verfahren zur Herstellung von neuen ω-Alkenylpropiolophenonen
AT308137B (de) Verfahren zur Herstellung von neuen substituierten N-Carbonylsulfonamiden
AT319257B (de) Verfahren zur Herstellung von neuen s-Triazinen
CH545298A (de) Verfahren zur Herstellung von substituierten s-Triazinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee